Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled Phase 2 trial of ubidecarenone (coenzyme Q10) in fibromyalgia
2011-005982-18Phase 2Active
- Sponsor
- Mónica Saldaña Valderas
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fibromyalgia (FM) comparing Ubidecarenone (coenzyme Q10) with Placebo (2 arms). Primary endpoint: Fibromyalgia Impact Questionnaire score change. Started Oct 2012; status: active.
02
Drugs
coenzyme q10
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2011-005982-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005982-18.